The Medicine Maker | The Medicine Maker

Musings from The Power List: Dajun Yang

September 15, 2026

The Ascentage Pharma CEO on why next-generation small molecules are expanding into territory once reserved for biologics

4 min read

Industry News

Personalized Cancer Vaccine Linked to Three-Year Disease-Free Survival in Head and Neck Cancer

All 16 patients who received TG4050 after standard treatment remained disease-free, compared with 13 of 16 patients in the control group

Cell & Gene

AI-Designed Binder Improves CAR T Cell Activity in Mice

Researchers screened 1,758 de novo protein binders and identified design features that influence CAR T cell activation, specificity, and tumor control

Cell & Gene

Biomarker Could Predict Response to Low-Dose CAR T Cell Therapy

CD27-negative, CD39-negative CAR T cells were associated with treatment response when limited cell numbers were administered

Future of Pharma

What Do Scientists Want from AI?

Scientists are already using AI in the lab – but many are doing so without the safeguards their employers may assume are in place

Cell & Gene Small Molecules Biopharma Future of Pharma

The voices driving change and progress in medicine making. Explore stories, interviews, and community highlights that inspire and inform.

Our celebration of the most inspirational and influential leaders in medicine.

Find out more

Ann Cleves

VP of Application Science, BioPharmics Division, Optibrium

View Profile

Bruce Levine

Barbara and Edward Netter Professor in Cancer Gene Therapy, University of Pennsylvania Perelman School of Medicine

View Profile

Musings from The Power List: Claudia Zylberberg

Claudia Zylberberg discusses building the infrastructure, partnerships, and policies needed to bring advanced therapies to patients at scale

Read the article

All the latest Medicine Maker articles.

Cell & Gene Business & Trends

Roving Reporter Asks: How Should We Redefine Value, Access, and Affordability in Cell and Gene Therapy?

September 11, 2026

IBTV speaks with industry leaders at ASGCT 2026 about new approaches to manufacturing, reimbursement, treatment delivery, and long-term value that could bring cell and gene therapies to more patients

1 min read

Small Molecules Drug Discovery Development & Clinical Interviews Power List

Musings from The Power List: Ali Tavassoli

September 10, 2026

Ali Tavassoli explains how cyclic peptides and new discovery tools are opening up once-inaccessible biology

8 min read

Biopharma Business & Trends Technology & Manufacturing

The Manufacturing Questions Facing Chinese Biotech

September 9, 2026

Lonza’s Wayne Wen discusses the growing maturity of China’s drug development and manufacturing ecosystem – and what companies need to compete internationally

5 min read

Cell & Gene Drug Discovery Development & Clinical Interviews Power List

Musings from The Power List: Miguel Forte

September 8, 2026

Scientific progress alone isn't enough, says Miguel Forte, who argues that reimbursement and patient access will shape the next decade of cell and gene therapy

4 min read

Cell & Gene Research News

CD19 CAR T Therapy Tested in Refractory Rheumatoid Arthritis

September 8, 2026

Disease activity fell in all six participants in a phase I trial, with three achieving sustained drug-free remission during follow-up

2 min read

Cell & Gene Technology & Manufacturing

Manufacturing Reality Behind Personalized Cancer Vaccines

September 7, 2026

As personalized cancer vaccines move closer to commercialization, manufacturers must rethink DNA production to deliver batch-for-one treatments with the required speed, consistency, and quality

3 min read

Research News Cell & Gene

CAR T Before Surgery Improves Glioblastoma Control in Mice

September 7, 2026

Study finds that tumor resection creates a more immunosuppressive environment and that earlier CAR T cell treatment prolongs survival

2 min read

Small Molecules Development & Clinical Small Molecules Power List Interviews

Musings from The Power List: Peng Lu

September 4, 2026

Peng Lu argues that small molecules remain indispensable as AI transforms drug development

2 min read

Future of Pharma Future of Pharma Business & Trends Power List

What Will Drug Development Look Like in 2036?

September 3, 2026

Members of The Medicine Maker’s 2026 Power List predict how AI, new modalities, integrated data, and shifting global markets will reshape the industry

7 min read

Drug Discovery

How Glycosylation Is Shaping Cancer Biomarker Discovery

September 2, 2026

Glycosylation could offer cancer researchers a new way to understand tumors, identify biomarkers, and develop more precise therapies

3 min read

Top Stories